Doximity DOCS
$28.73 −$0.88 (-2.97%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $28.46 -0.94%
Open$29.32
Prev close$29.61
Day range$28.55 – $29.86
Volume2.38M
Market cap$5.13B
P/E (TTM)39.9
Dividend yield–
Earnings
Average move on report day±19.6%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+38.7%
Worst reaction-23.0%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2027/Q2 | 5 Nov 2026 | After Market | ±17.1% | -2.02% | Within range |
| 2027/Q1 | 6 Aug 2026 | After Market | ±17.5% | +32.62% | Bigger than priced |
| 2026/Q4 | 13 May 2026 | After Market | ±16.4% | -23.00% | Bigger than priced |
| 2026/Q3 | 5 Feb 2026 | After Market | ±20.5% | -16.78% | Within range |
| 2026/Q2 | 6 Nov 2025 | After Market | ±16.9% | -13.25% | Within range |
| 2026/Q1 | 7 Aug 2025 | After Market | ±17.4% | +13.71% | Within range |
| 2025/Q4 | 15 May 2025 | After Market | ±20.9% | -10.08% | Within range |
| 2025/Q3 | 6 Feb 2025 | After Market | ±19.2% | +35.99% | Bigger than priced |
| 2025/Q2 | 7 Nov 2024 | After Market | ±15.5% | +34.15% | Bigger than priced |
| 2025/Q1 | 8 Aug 2024 | After Market | ±17.2% | +38.74% | Bigger than priced |
| 2024/Q4 | 16 May 2024 | After Market | ±20.6% | +18.07% | Within range |
| 2024/Q3 | 8 Feb 2024 | After Market | ±15.8% | +1.24% | Within range |
| 2024/Q1 | 8 Aug 2023 | After Market | ±16.6% | -22.84% | Bigger than priced |
| 2023/Q4 | 16 May 2023 | After Market | ±13.9% | -5.67% | Within range |
| 2023/Q3 | 9 Feb 2023 | After Market | ±15.3% | -12.88% | Within range |
| 2023/Q2 | 10 Nov 2022 | After Market | ±20.5% | +32.70% | Bigger than priced |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q2, ended Sep 2026
Revenue$174.54M+3.6% YoY
Operating profit$43.92M-31.0% YoY
Net profit$34.73M-44.0% YoY
Diluted EPS$0.18-41.9% YoY
Free cash flow$91.33M-0.3% YoY
Operating cash flow$93.29M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin86.8%
Operating margin26.3%
Net margin21.1%
Return on equity13.8%
Return on assets11.9%
Return on invested capital11.6%
Current ratio6.37
Liabilities / assets15.0%
Cash & investments$713.23M
Total debt$6.95M
Net cash (debt)$706.28M
Free cash flow / sales44.9%
No comments yet — be the first to weigh in on DOCS.
Sign in to join the discussion.